Doximity, Inc. (DOCS) Tops Q3 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Doximity Announces Fiscal 2026 Third Quarter Financial Results
February 5, 2026 4:01 PM ESTTotal revenues of $185.1 million, up 10% year-over-year
Net income of $61.6 million, margin of 33%
Adjusted EBITDA of $111.4 million, margin of 60%
SAN FRANCISCO--(BUSINESS WIRE)-- Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2026 third quarter ended December 31, 2025.
Were proud to deliver another quarter of strong profits and record engagement, said Jeff Tangney, co-founder and CEO of Doximity. Our newsfeed had more than 1 million quarterly active prescribers, our workflow... More
